This inventor holds 2 USPTO granted patents. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1983.
Company Filing History:
Years Active: 1983
Title: Richard D Woolfenden: Innovator in Pharmaceutical Chemistry
Introduction
Richard D Woolfenden is a notable inventor based in Bridgend, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the stabilization of pleuromutilin derivatives. With a total of 2 patents, his work has implications for treating infections in farm animals.
Latest Patents
Woolfenden's latest patents focus on the stabilization of pleuromutilin derivatives against oxidation by sodium. One of his compositions provides a compound of a specific formula, wherein R1 can be either ethyl or vinyl. The invention also includes a hypochlorite scavenger in solution that stabilizes the compound against oxidation by sodium hypochlorite. A preferred solution contains the compound where R1 is vinyl, and R2 and R3 are ethyl, formulated as a salt of hydrogen fumarate, specifically tiamulin hydrogen fumarate. This solution is intended to be added to drinking water for farm animals to treat mycoplasma infections.
Career Highlights
Woolfenden is currently associated with E. R. Squibb Sons, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing effective treatments for various infections, showcasing his expertise in the field.
Collaborations
One of his notable collaborators is Frank Ridgway, with whom he has worked on various projects related to his patents.
Conclusion
Richard D Woolfenden's contributions to pharmaceutical chemistry, particularly through his patents, highlight his role as an innovator in the industry. His work not only advances scientific knowledge but also provides practical solutions for animal health.